Sildosin as a Male Contraceptive Non Hormonal
ConditionContraception Use
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexMale
Age20+
SponsorBenha University
About this trial
In all, 200 healthy, sexually active, fertile male candidates will be assigned 100 in silodosin group and 100 in placebo group. Males using other contraceptive methods will be excluded. Follow up data of total spermatozoa per ejaculate, semen volume and Post-ejaculation urinalysis after 2, 6 and 12 weeks of the studied groups will be recorded. The various side effects reported in the study groups after 12 weeks from the start of the study will be recorded.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
male sexually active
Disqualifiers
male on oral contraceptives Male with female partner on contraceptives
Trial design
Design model
Parallel
Treatments tested in this trial
Oral intake of sildosin
DrugOral intake of sildosin in male non hormonal contraception
Oral intake of placebo
Other interventionIntake of placebo to compare effecacy of other group
Treatment groups
200 Participants
are divided into 2 treatment groupsGroup A: Sildosin armActive comparator 1 intervention
Group B: Placebo armPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
Pregnancy rate in people treated with sildosin as a male contraceptive
Pregnancy rate in people treated with sildosin as a male contraceptive treatment
Time frame
3 monthsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: